| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fe76949cd566430d9d83a068bab21e1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate |
2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2023-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a81ae06c1f3c985664bfb92ff3eb27c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba01143cdf0f85b7439ebe253605377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1317e0fba81c5243a9ce3995a4cd4f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b997c71f959b67c97069b9490d2aa62b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8afc16c624ed12463a91639f5ac230 |
| publicationDate |
2023-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11649231-B2 |
| titleOfInvention |
Compound as mTOR inhibitor and use thereof |
| abstract |
The present invention relates to a novel compound as an mTOR inhibitor and a use thereof and, more specifically, to a novel compound represented by formula 1 that exhibits mTOR inhibitory activity and a pharmaceutical composition comprising same as an active ingredient for preventing or treating brain diseases associated with an mTOR pathway. |
| priorityDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |